
86.35 Delayed Data As of Dec 13 | ![]() Today’s Change | 65.44 Today|||52-Week Range 88.76 | +19.38% Year-to-Date |
Is Abbott Laboratories Stock a Buy? Dec 08 / MotleyFool.com - Paid Partner Content | Despite the Naysayers, AbbVie Keeps Marching On Dec 03 / MotleyFool.com - Paid Partner Content |
Previous close | 85.97 |
Today’s open | 85.78 |
Day’s range | 85.78 - 86.71 |
Volume | 3,872,210 |
Average volume (3 months) | 4,507,948 |
Market cap | $152.8B |
Earnings growth (last year) | +397.55% |
Earnings growth (this year) | +12.59% |
Earnings growth (next 5 years) | +11.00% |
Revenue growth (last year) | +11.64% |
P/E ratio | 46.9 |
Price/Sales | 4.19 |
Price/Book | 4.97 |
Today’s change | Today’s % change | |
---|---|---|
BDXBecton Dickinson and... | +3.28 | +1.24% |
BSXBoston Scientific Co... | +0.42 | +0.94% |
BAXBaxter International... | +0.45 | +0.54% |
ZBHZimmer Biomet Holdin... | +0.66 | +0.45% |
Next reporting date | January 24, 2020 |
EPS forecast (this quarter) | $0.95 |
Annual revenue (last year) | $30.6B |
Annual profit (last year) | $2.4B |
Net profit margin | 7.58% |
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Abbott Park, Illinois |